DK1841758T3 - Substituerede triazol-derivater som oxytocin-antagonister - Google Patents
Substituerede triazol-derivater som oxytocin-antagonisterInfo
- Publication number
- DK1841758T3 DK1841758T3 DK06710261.6T DK06710261T DK1841758T3 DK 1841758 T3 DK1841758 T3 DK 1841758T3 DK 06710261 T DK06710261 T DK 06710261T DK 1841758 T3 DK1841758 T3 DK 1841758T3
- Authority
- DK
- Denmark
- Prior art keywords
- triazole derivatives
- substituted triazole
- oxytocin antagonists
- oxytocin
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0501190.3A GB0501190D0 (en) | 2005-01-20 | 2005-01-20 | Novel pharmaceuticals |
| PCT/IB2006/000118 WO2006077496A1 (en) | 2005-01-20 | 2006-01-11 | Substituted triazole derivatives as oxytocin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1841758T3 true DK1841758T3 (da) | 2010-01-18 |
Family
ID=34259404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06710261.6T DK1841758T3 (da) | 2005-01-20 | 2006-01-11 | Substituerede triazol-derivater som oxytocin-antagonister |
Country Status (32)
| Country | Link |
|---|---|
| US (5) | US7557131B2 (da) |
| EP (1) | EP1841758B1 (da) |
| JP (1) | JP4124805B1 (da) |
| KR (1) | KR100936854B1 (da) |
| CN (1) | CN101107243B (da) |
| AP (1) | AP2007004047A0 (da) |
| AR (1) | AR055303A1 (da) |
| AT (1) | ATE449091T1 (da) |
| AU (1) | AU2006207300B2 (da) |
| BR (1) | BRPI0606463A2 (da) |
| CA (1) | CA2595569C (da) |
| CR (1) | CR9219A (da) |
| DE (1) | DE602006010508D1 (da) |
| DK (1) | DK1841758T3 (da) |
| DO (1) | DOP2006000014A (da) |
| EA (1) | EA200701328A1 (da) |
| ES (1) | ES2334517T3 (da) |
| GB (1) | GB0501190D0 (da) |
| GT (1) | GT200600024A (da) |
| HK (1) | HK1113927A1 (da) |
| IL (1) | IL184148A (da) |
| MA (1) | MA29160B1 (da) |
| MX (1) | MX2007008757A (da) |
| NL (1) | NL1030961C2 (da) |
| NO (1) | NO338420B1 (da) |
| PA (1) | PA8660401A1 (da) |
| PE (1) | PE20060875A1 (da) |
| TN (1) | TNSN07275A1 (da) |
| TW (1) | TW200637847A (da) |
| UY (1) | UY29339A1 (da) |
| WO (1) | WO2006077496A1 (da) |
| ZA (1) | ZA200705718B (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06284516A (ja) * | 1993-03-31 | 1994-10-07 | Mitsubishi Electric Corp | 電気車制御装置 |
| AP2007004047A0 (en) | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
| GB0504556D0 (en) * | 2005-03-04 | 2005-04-13 | Pfizer Ltd | Novel pharmaceuticals |
| AU2006255465A1 (en) * | 2005-06-09 | 2006-12-14 | Merck Frosst Canada Ltd | Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| GB0607196D0 (en) * | 2006-04-11 | 2006-05-17 | Prosidion Ltd | G-protein coupled receptor agonists |
| AU2007260527A1 (en) * | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Azetidine derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| CA2654098A1 (en) * | 2006-06-13 | 2007-12-21 | Merck Frosst Canada Ltd. | Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| JP2010527915A (ja) * | 2007-04-26 | 2010-08-19 | アバロン ファーマシューティカルズ，インコーポレイテッド | 多重環化合物及びその用途 |
| CA2712854C (en) | 2008-01-31 | 2016-02-23 | Sanofi-Aventis | Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| ES2430621T3 (es) * | 2008-01-31 | 2013-11-21 | Sanofi | Azaindol-3-carboxamidas cíclicas, su preparación y su uso como productos farmacéuticos |
| WO2014014834A1 (en) * | 2012-07-16 | 2014-01-23 | Fibrogen, Inc. | Process for making isoquinoline compounds |
| WO2016014975A2 (en) | 2014-07-25 | 2016-01-28 | Northeastern University | Urea/carbamates faah magl or dual faah/magl inhibitors and uses thereof |
| JOP20190072A1 (ar) * | 2016-10-13 | 2019-04-07 | Glaxosmithkline Ip Dev Ltd | مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم |
| PL3541784T3 (pl) | 2016-11-18 | 2024-03-11 | Integrative Research Laboratories Sweden Ab | Nowe pochodne azetydyny użyteczne jako modulatory korowego nuroprzekaźnictwa katecholaminergicznego |
| EP3560918A4 (en) * | 2016-12-21 | 2020-05-20 | Jiangsu Hengrui Medicine Co., Ltd. | TRIAZOLE DERIVATIVE FROM THE CONDENSED CYCLE AZACYCLOBUTYL GROUP, PREPARATION METHOD THEREOF AND USE IN MEDICINE |
| AU2017389819B2 (en) * | 2016-12-28 | 2021-05-27 | Jiangsu Hengrui Medicine Co., Ltd. | Azabicyclo-substituted triazole derivative, preparation method thereof, and application of same in medicine |
| CN111094273B (zh) * | 2018-06-20 | 2022-04-12 | 江苏恒瑞医药股份有限公司 | 催产素受体抑制剂的晶型及其制备方法 |
| CN111094272B (zh) * | 2018-06-20 | 2022-05-27 | 江苏恒瑞医药股份有限公司 | 一种otr抑制剂的可药用盐、晶型及制备方法 |
| CN111902406B (zh) * | 2018-06-27 | 2022-11-18 | 江苏恒瑞医药股份有限公司 | 氮杂双环基取代的三唑类衍生物的可药用盐、晶型及制备方法 |
| CN113004250B (zh) * | 2019-12-19 | 2022-07-26 | 上海森辉医药有限公司 | 一种制备取代的三唑衍生物的方法 |
| CN113582818B (zh) * | 2021-08-30 | 2023-08-01 | 上海日异生物科技有限公司 | 一种3-卤-2-烷基苯酚的合成方法 |
| WO2023156386A2 (en) * | 2022-02-16 | 2023-08-24 | Duke Street Bio Limited | Pharmaceutical compound |
| CN114805161B (zh) * | 2022-06-14 | 2023-08-25 | 南通华祥医药科技有限公司 | 一种3-氟丫丁啶盐酸盐的制备方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554276A (en) | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
| US5053411A (en) | 1989-04-20 | 1991-10-01 | Anaquest, Inc. | N-aryl-N-[4-(1-heterocyclicalkyl)piperidinyl]amides and pharmaceutical compositions and methods employing such compounds |
| DE4124942A1 (de) | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4302051A1 (de) | 1993-01-26 | 1994-07-28 | Thomae Gmbh Dr K | 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| EP0891334A1 (en) | 1996-04-03 | 1999-01-20 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| AU716381B2 (en) | 1996-04-03 | 2000-02-24 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| CA2249665A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| JP2000507956A (ja) | 1996-04-03 | 2000-06-27 | メルク エンド カンパニー インコーポレーテッド | ファルネシル−タンパク質トランスフェラーゼ阻害剤 |
| AU6013998A (en) | 1996-12-30 | 1998-07-31 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| EA200000526A1 (ru) | 1997-12-16 | 2000-12-25 | Пфайзер Продактс Инк. | Комбинация, эффективная для лечения импотенции |
| AU763976B2 (en) | 1999-07-23 | 2003-08-07 | Shionogi & Co., Ltd. | Th2 differentiation inhibitors |
| BR0014859A (pt) | 1999-10-15 | 2002-07-16 | Hoffmann La Roche | Derivados de benzodiazepina |
| AU779426B2 (en) | 1999-11-15 | 2005-01-27 | Janssen Pharmaceutica N.V. | Triazoles as farnesyl transferase inhibitors |
| WO2001076582A1 (fr) | 2000-04-05 | 2001-10-18 | Shionogi & Co., Ltd. | Micro-emulsions huile dans eau contenant des composes tricycliques ou des preconcentres de ceux-ci |
| US20030216385A1 (en) | 2000-05-19 | 2003-11-20 | Takahiko Tobe | Triazole derivatives |
| CN1237055C (zh) * | 2000-05-19 | 2006-01-18 | 山之内制药株式会社 | 三唑衍生物 |
| MXPA04003170A (es) | 2001-10-03 | 2004-07-08 | Pharmacia Corp | Compuestos policiclicos, sustituidos, provisto de 5 miembros, utiles para la inhibicion selectiva de la cascada de coagulacion. |
| GB0130677D0 (en) | 2001-12-21 | 2002-02-06 | Glaxo Group Ltd | Medicaments and novel compounds |
| GB0208579D0 (en) | 2002-04-13 | 2002-05-22 | British Biotech Pharm | Antibacterial agents |
| GB0224919D0 (en) | 2002-10-25 | 2002-12-04 | Pfizer Ltd | Triazole compounds useful in therapy |
| US20040167188A1 (en) | 2003-02-14 | 2004-08-26 | Zhili Xin | Protein-tyrosine phosphatase inhibitors and uses thereof |
| US7169797B2 (en) | 2003-02-14 | 2007-01-30 | Abbott Laboratories | Protein-tyrosine phosphatase inhibitors and uses thereof |
| WO2005028452A1 (en) * | 2003-09-22 | 2005-03-31 | Pfizer Limited | Substituted triazole derivatives as oxytocin antagonists |
| AU2004309164B2 (en) | 2003-12-22 | 2007-11-15 | Pfizer Inc. | Triazole derivatives as vasopressin antagonists |
| WO2005082866A2 (en) * | 2004-02-20 | 2005-09-09 | Pfizer Limited | Substituted 1, 2, 4- triazole derivatives as oxytocin antagonists |
| WO2005105779A1 (en) | 2004-04-28 | 2005-11-10 | Pfizer Limited | 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor |
| AP2007004047A0 (en) | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
-
2005
- 2005-01-11 AP AP2007004047A patent/AP2007004047A0/xx unknown
- 2005-01-20 GB GBGB0501190.3A patent/GB0501190D0/en not_active Ceased
-
2006
- 2006-01-11 EA EA200701328A patent/EA200701328A1/ru unknown
- 2006-01-11 BR BRPI0606463-9A patent/BRPI0606463A2/pt not_active IP Right Cessation
- 2006-01-11 DK DK06710261.6T patent/DK1841758T3/da active
- 2006-01-11 AU AU2006207300A patent/AU2006207300B2/en active Active
- 2006-01-11 MX MX2007008757A patent/MX2007008757A/es active IP Right Grant
- 2006-01-11 KR KR1020077016553A patent/KR100936854B1/ko active IP Right Grant
- 2006-01-11 CA CA2595569A patent/CA2595569C/en active Active
- 2006-01-11 EP EP06710261A patent/EP1841758B1/en active Active
- 2006-01-11 AT AT06710261T patent/ATE449091T1/de not_active IP Right Cessation
- 2006-01-11 WO PCT/IB2006/000118 patent/WO2006077496A1/en active Application Filing
- 2006-01-11 DE DE602006010508T patent/DE602006010508D1/de active Active
- 2006-01-11 JP JP2007551766A patent/JP4124805B1/ja active Active
- 2006-01-11 CN CN2006800028617A patent/CN101107243B/zh active Active
- 2006-01-11 ES ES06710261T patent/ES2334517T3/es active Active
- 2006-01-17 PE PE2006000072A patent/PE20060875A1/es not_active Application Discontinuation
- 2006-01-17 DO DO2006000014A patent/DOP2006000014A/es unknown
- 2006-01-18 AR ARP060100188A patent/AR055303A1/es unknown
- 2006-01-18 UY UY29339A patent/UY29339A1/es active IP Right Grant
- 2006-01-19 TW TW095102071A patent/TW200637847A/zh unknown
- 2006-01-19 NL NL1030961A patent/NL1030961C2/nl active Search and Examination
- 2006-01-19 GT GT200600024A patent/GT200600024A/es unknown
- 2006-01-20 PA PA20068660401A patent/PA8660401A1/es unknown
- 2006-01-20 US US11/335,940 patent/US7557131B2/en active Active
-
2007
- 2007-06-21 IL IL184148A patent/IL184148A/en active IP Right Grant
- 2007-07-02 CR CR9219A patent/CR9219A/es not_active Application Discontinuation
- 2007-07-11 ZA ZA200705718A patent/ZA200705718B/xx unknown
- 2007-07-19 TN TNP2007000275A patent/TNSN07275A1/fr unknown
- 2007-07-20 MA MA30089A patent/MA29160B1/fr unknown
- 2007-08-14 NO NO20074177A patent/NO338420B1/no unknown
-
2008
- 2008-03-19 HK HK08103169.1A patent/HK1113927A1/xx unknown
-
2009
- 2009-05-15 US US12/466,785 patent/US8207198B2/en active Active
-
2012
- 2012-05-23 US US13/478,384 patent/US9023872B2/en active Active
-
2015
- 2015-04-20 US US14/691,319 patent/US9394278B2/en active Active
-
2016
- 2016-06-28 US US15/195,480 patent/US10150752B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1841758T3 (da) | Substituerede triazol-derivater som oxytocin-antagonister | |
| DK1926722T3 (da) | Substituerede benzimidazoler som kinaseinhibitorer | |
| DK1863818T3 (da) | Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister | |
| CY2013047I1 (el) | Ενωσεις διαρυλυδαντοϊνης | |
| DK1919907T3 (da) | Heterocyklisk forbindelse | |
| ATE511502T1 (de) | Arylpropionamid-, arylacrylamid-, arylpropinamid- oder arylmethylharnstoffanaloge als faktor-xia- inhibitoren | |
| DK1959951T3 (da) | Heteroaryl-substituerede piperidinderivater som L-CPT1-inhibitorer | |
| ATE517886T1 (de) | Pyrazolderivate | |
| DK1586319T3 (da) | Thiadiazolidinoner som GSK-3-inhibitorer | |
| DK1856042T3 (da) | Substituerede gamma-lactamer som terapeutiske midler | |
| NL1031385A1 (nl) | Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen. | |
| ATE443056T1 (de) | Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen | |
| DK2170831T3 (da) | Benzazepin-derivater egnede som vasopressin-antagonister | |
| DE602006021644D1 (de) | Fungizidzusammensetzungen | |
| DK1937650T3 (da) | Heterocykliske forbindelser | |
| DK1740569T3 (da) | Imidazol-derivater som TAFla-inhibitorer | |
| DE112005003586A5 (de) | Bohrfutter | |
| DE602006010581D1 (de) | 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate | |
| ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
| ATE404546T1 (de) | Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen | |
| DE502006001027D1 (de) | Cyanuraten | |
| ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
| DK1971588T3 (da) | Tiglien-3-onderivater | |
| DE502006005182D1 (de) | Heterocyclylamid-substituierte imidazole | |
| ATE435865T1 (de) | Als pde5-inhibitoren verwendete pyrazoloä4,3- düpyrimidin-5-ylderivate |